• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR NC TREK CORONARY DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR NC TREK CORONARY DILATATION CATHETER Back to Search Results
Model Number 1012455-12
Device Problems Deflation Problem (1149); Failure to Fold (1255); Difficult to Remove (1528); Improper or Incorrect Procedure or Method (2017)
Patient Problems Non specific EKG/ECG Changes (1817); Ischemia (1942)
Event Date 11/26/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure performed was to treat a left coronary (lm) artery.A 5.0x12mm nc trek balloon dilatation catheter was inflated twice at 15 to 16 atmospheres.It was noted that the balloon partially deflated only at the distal and proximal ends; the center still remained inflated.During removal of the balloon, which was still partially inflated, and non-abbott guide wire, force was applied and it was noted the patient's electrocardiogram (ecg) was altered and identified myocardial ischemia.However; the patient did not receive any treatment and the altered ecg and myocardial ischemia resolved after balloon removal.Also, the balloon appeared to look deformed once removed.There was no clinically significant delay reported.No additional information was provided.
 
Manufacturer Narrative
Device code 2017 / contrast incorrect.Visual, dimensional and functional inspections were performed on the returned device.The reported failure to fold (deformed balloon) was confirmed; however, the reported deflation issue could not be confirmed.The reported difficulty to remove could not be replicated in a testing environment as it was based on operational circumstances.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents and/or complaints from this lot.The investigation was unable to determine a conclusive cause for the reported deflation issue; however, the reported failure to fold (deformed balloon) and difficulty removing the device appears to be related to operational context.In this case, a conclusive cause for the reported deflation issue could not be determined since the complaint could not be confirmed during return analysis.Return analysis noted wrinkles sporadically through out the entire length of the balloon.In this case, since the device had a larger balloon profile and the balloon was attempted to be removed partially inflated, it ultimately became wrinkled/bunched and gave the impression of a deformed balloon.Furthermore, the reported difficulty removing the device was due to the balloon being removed partially inflated as deflation could not be completed.Force was applied and it was noted the patient's electrocardiogram (ecg) was altered and identified myocardial ischemia.A conclusive cause for the reported ekg/ecg changes and ischemia and the relationship to the device, if any, cannot be determined.It should be noted that the coronary dilatation catheters (cdc), nc trek rx, global, instruction for use (ifu) specified that the contrast is 60% contrast medium diluted 1:1 with normal saline.In this case, since the contrast ratio used was less than the required percentage it is unknown if the ifu violation caused or contributed to the reported complaint.It should be noted that coronary dilatation catheters (cdc), nc trek rx, global, instruction for use (ifu) states: if resistance is felt, determine the cause before proceeding.Continuing to advance or retract the catheter while under resistance may result in damage to the vessels and / or damage / separation of the catheter.In this case, the device was removed against resistance given the clinical circumstances.There is no indication of a product quality issue with respects to the design, manufacture, or labeling of the device.H10: device code 2017 - contrast incorrect was added.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NC TREK CORONARY DILATATION CATHETER
Type of Device
CORONARY DILATATION CATHETER
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key11043120
MDR Text Key223175999
Report Number2024168-2020-10749
Device Sequence Number1
Product Code LOX
UDI-Device Identifier08717648152146
UDI-Public08717648152146
Combination Product (y/n)N
PMA/PMN Number
K103153
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 02/23/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/20/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2023
Device Model Number1012455-12
Device Catalogue Number1012455-12
Device Lot Number00610G1
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/06/2021
Date Manufacturer Received02/02/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
SION GUIDE WIRE
Patient Outcome(s) Other;
-
-